))
#6 - Ozempic and Beyond: Changing Tides in Health, Society, and Industry
Manage episode 391944817 series 3493130
Content provided by Gustavo Franco. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Gustavo Franco or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Join us on "The Gustavo Franco Podcast" for a riveting exploration of Ozempic and other GLP-1 drugs, which are reshaping more than just diabetes and obesity treatment. This episode ventures beyond healthcare, revealing the profound impact of these drugs on society, economy, and even fashion and fast food industries. Engage with us as we unravel the ethical debates and lifestyle transformations stemming from this pharmaceutical phenomenon. Don't miss the chance to discover the extensive influence of Ozempic and GLP-1 drugs in an episode packed with intriguing and insightful discussions.
Researched and produced by Brian Li.
Timestamps:
(00:00:00) - Channel Intro
(00:02:00) - Episode Introduction
(00:04:41) - GLP-1 Drugs
(00:07:16) - Biology
(00:09:39) - Pharmaceutical Development
(00:15:17) - Rise to Fame
(00:18:19) - Growth of Industry
(00:20:14) - Ozempic’s Dual Use
(00:22:02) - Wegovy for Obesity
(00:24:10) - Introducing Zepbound
(00:25:23) - Off-Label Use
(00:27:10) - Accessibility and Inequality
(00:29:02) - Employer and Government Initiatives to Improve Access
(00:31:08) - Impact on Industry: Fast Food, Fashion, Air Travel
(00:40:28) - Obesity Spending
(00:42:44) - Economic Implications in Healthcare
(00:44:56) - Medical Technology and Dieting Industries
(00:48:03) - Healthcare System: Good or Bad?
(00:50:31) - Health Paradigm Shift
(00:52:43) - Exacerbating Social Inequalities
(00:54:05) - Ethical Considerations: Root Causes, Dependency, Side Effects, Long Term Risks, Children, Consent, Autonomy, Marketing
(01:04:47) - Addiction Potential
(01:06:55) - Conclusion
(01:09:10) - Outro
Contact us here.
Linktree: linktr.ee/gustavofrancopod
Capitole
1. Channel Intro (00:00:00)
2. Episode Introduction (00:02:00)
3. GLP-1 Drugs (00:04:41)
4. Biology (00:07:16)
5. Pharmaceutical Development (00:09:39)
6. Rise to Fame (00:15:17)
7. Growth of Industry (00:18:19)
8. Ozempic's Dual Use (00:20:14)
9. Wegovy for Obesity (00:22:02)
10. Introducing Zepbound (00:24:10)
11. Off-Label Use (00:25:23)
12. Accessibility and Inequality (00:27:10)
13. Employer and Government Initiatives to Improve Access (00:29:02)
14. Impact on Industry: Fast Food, Fashion, Air Travel (00:31:08)
15. Obesity Spending (00:40:28)
16. Economic Implications in Healthcare (00:42:44)
17. Medical Technology and Dieting Industries (00:44:56)
18. Healthcare System: Good or Bad? (00:48:00)
19. Health Paradigm Shift (00:50:31)
20. Exacerbating Social Inequalities (00:52:43)
21. Ethical Considerations: Root Causes, Dependency, Side Effects, Long Term Risks, Teenagers, Consent, Autonomy, Marketing (00:54:05)
22. Addiction Potential (01:04:47)
23. Conclusion (01:06:55)
24. Outro (01:09:10)
17 episoade
Distribuie
